[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Ndao, 2012 - Google Patents

Biomarker discovery in serum/plasma using surface enhanced laser desorption ionization time of flight (SELDI–TOF) Mass Spectrometry

Ndao, 2012

Document ID
477939939923640230
Author
Ndao M
Publication year
Publication venue
SELDI-TOF Mass Spectrometry: Methods and Protocols

External Links

Snippet

Proteins and peptides that undergo variations in concentration or state as a result of a biological process or disease may be used as biomarkers for the diagnosis or prognosis of diseases and/or for the monitoring of therapy. Serum/plasma is one of the most easily …
Continue reading at link.springer.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/558—Immunoassay; Biospecific binding assay using diffusion or migration of antigen or antibody
    • G01N33/561—Immunoelectrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/447—Systems using electrophoresis
    • G01N27/44704—Details; Accessories
    • G01N27/44717—Arrangements for investigating the separated zones, e.g. localising zones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases

Similar Documents

Publication Publication Date Title
Ray et al. Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead
Luque-Garcia et al. Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry
US8389222B2 (en) Apolipoprotein fingerprinting technique and methods related thereto
Tuli et al. LC–MS based detection of differential protein expression
Kim et al. Affinity enrichment for mass spectrometry: improving the yield of low abundance biomarkers
Colantonio et al. The clinical application of proteomics
KR20080080390A (en) Systems and methods involving data patterns such as spectral biomarkers
US20040235052A1 (en) Assay customization
Ndao Biomarker discovery in serum/plasma using surface enhanced laser desorption ionization time of flight (SELDI–TOF) Mass Spectrometry
WO2008122241A1 (en) Rapid protein analyses and the device thereof
Gulcicek et al. Proteomics and the analysis of proteomic data: an overview of current protein‐profiling technologies
Boschetti et al. " The quest for biomarkers": Are we on the right technical track?
Plebani et al. Recent advances in diagnostic technologies for autoimmune diseases
Hodgetts et al. Biomarker discovery in infectious diseases using SELDI
Roy et al. Differential expression profiling of serum proteins and metabolites for biomarker discovery
Issaq et al. Electrophoresis and liquid chromatography/tandem mass spectrometry in disease biomarker discovery
De Palma et al. Extraction methods of red blood cell membrane proteins for Multidimensional Protein Identification Technology (MudPIT) analysis
McGuire et al. Mass spectrometry is only one piece of the puzzle in clinical proteomics
Davis et al. High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy
Ndao et al. Is SELDI-TOF a valid tool for diagnostic biomarkers?
KR100968334B1 (en) Method for detecting multiple analytes for use in a biosensor
EP1006362A1 (en) Method and apparatus for the separation of components from a biological material
Yip et al. Application of ProteinChip array profiling in serum biomarker discovery for patients suffering from severe acute respiratory syndrome
Lee et al. Alternative workflows for plant proteomic analysis
Hong et al. Proteomics technology and therapeutics